Cargando…
Long-term use and tolerability of irbesartan for control of hypertension
In this review, we discuss the pharmacological and clinical properties of irbesartan, a noncompetitive angiotensin II receptor type 1 antagonist, successfully used for more than a decade in the treatment of essential hypertension. Irbesartan exerts its antihypertensive effect through an inhibitory e...
Autores principales: | Forni, Valentina, Wuerzner, Grégoire, Pruijm, Menno, Burnier, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172075/ https://www.ncbi.nlm.nih.gov/pubmed/21949635 http://dx.doi.org/10.2147/IBPC.S12211 |
Ejemplares similares
-
Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study
por: Forni Ogna, Valentina, et al.
Publicado: (2013) -
How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice
por: Polychronopoulou, Erietta, et al.
Publicado: (2021) -
Hypertension and Drug Adherence in the Elderly
por: Burnier, Michel, et al.
Publicado: (2020) -
New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy
por: Damianaki, Aikaterini, et al.
Publicado: (2021) -
Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
por: Burnier, Michel, et al.
Publicado: (2005)